Fig. 3From: Identification of dual STRN-NTRK2 rearrangements in a high grade sarcoma, with good clinical response to first-line larotrectinib therapyMolecular characterization of tumor sample by NGS. Two in-frame STRN-NTRK2 fusions with same 5’ partner sequence (exons 1–3) of STRN gene identified by NGS.Back to article page